Categories
Market Outlook Market Reports Market Research

Global Home Therapeutic Equipment Market Is Expected to Grow At A CAGR of 9.2% from 2020 to 2027

A paradigm shift has occurred in the home therapeutic equipment market due to a reduction in mortality rate by 19% due to better functional outcomes of patients, monetary savings for home hospice in comparison to huge healthcare burden associated with inpatient hospital settings, etc.

Respiratory therapy equipments are reigning the components segment for the home therapeutic equipment market. A significant increase in minimally invasive surgical procedures and a growing incidence of respiratory diseases together drive the market growth. Rising prevalence of sleep apnea creates an increasing demand for continuous positive airway pressure therapy devices in homecare settings. Dialysis equipment is expected to record rampant market growth in the near future on account of the rising prevalence of chronic kidney diseases worldwide. According to the latest statistics provided by the National Kidney Foundation (NKF), it is estimated that annually 7.1 million people worldwide die with end-stage kidney disease due to a lack of access to dialysis.

Browse the full report Home Therapeutic Equipment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/home-therapeutic-equipment-market

Retail outlets are presently dominating the distribution channel segment for the home therapeutic equipment market. Medical device companies after the manufacturing of medical devices put them for exhibition and sale in their respective retail outlets. Free demonstration of the medical device operating system and availability of various purchasing options promotes its market superiority. E-commerce is keen to highlight comfortable market growth during the forecast period owing to the deep penetration of the internet and access to smartphones by the consumers and sale of therapeutic equipment at affordable prices and opportunities to win attractive discount coupons and gift vouchers.

North America is currently leading the geography segment for the home therapeutic equipment market. The rising prevalence of chronic lifestyle disorders primarily drives market growth in the region. As per the latest research citings presented by the Center for Disease Control and Prevention (CDC), approximately 1 in 4 adults are suffering from more than 2 or more chronic disorders. Domicile of key players such as GE Healthcare, Smiths Medical, Becton, Dickinson and Company, Medline Industry, Inc., etc. further propel the market growth in the region. Europe is placed in the 2nd position in the regional segment owing to the nurturing regulatory environment provided by the European Medical Agency (EMA), in the early CE clearance and adoption of medical devices for therapeutic purposes. The Asia Pacific is anticipated to be the fastest-growing regional segment in the home therapeutic equipment market. The emergence of local players creates a hugely competitive market for western giants which provides an assertive impetus on the home therapeutic equipment market growth in the region.

Medical device manufacturers actively engaged in the production of home therapeutic equipment are GE Healthcare, Drägerwerk AG & Co., Medtronic, Plc., Fresenius Kabi AG, Nipro Corporation, Philips Healthcare, Smiths Medical, Novo Nordisk A/S, Becton, Dickinson and Company and Medline Industry, Inc.

Key Market Movements:

  • Rising prevalence of lifestyle chronic diseases worldwide
  • Technological advancement in the medical devices associated with homecare settings to propel the market growth
  • Nurturing regulatory environment by the healthcare agencies by providing early CE clearance and adoption of medical devices for therapeutic purposes

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Market Outlook Market Reports Market Research

Global High Definition Breast Tomosynthesis Market is expected to grow at a CAGR of 13.5% from 2020 to 2027

Breast tissues attain different morphology at different stages of life primarily influenced by the hormonal levels and environmental factors affecting the human body. High definition tomosynthesis is an up-gradation to the earlier versions of digital breast tomosynthesis which is useful in achieving high-resolution images and videos of breast cancer cells and tissue under investigation. Breast tomosynthesis employs a low radiation dose by employing an x-ray tube that moves like an arc achieving breast images from different angles to create multiple data points that can be reconstructed in different ways for effective diagnosis of breast cancer cases.

2D/3D combination systems are presently leading the product segment for high definition breast tomosynthesis market. The major factor responsible for its technical viability among oncologists is its capability to precisely analyze the calcification and no calcification cases of breast cancer which is relatively difficult to analyze by employing either dimensional system. Standalone 3D systems are very crucial in screening breast cancer owing to its excellent ergonomic features such as increased sensitivity and reduced recalls rendering it to effectively diagnose invasive cancer cases and reduction in false-positive cases.

Browse the full report High Definition Breast Tomosynthesis Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/high-definition-breast-tomosynthesis-market

Hospitals are dominating the end-user segment for the high definition breast tomosynthesis market. The primary health care centers are the first point of contact for patients opting for early screening of breast cancer. Government health agencies are providing huge funds for the establishment of well-equipped devices for performing screening of breast cancer. Diagnostic centers have gained tremendous traction in the last decade on account of the availability of a skilled workforce for the operating of sophisticated breast tomosynthesis devices and precise interpretation of images.

North America is holding the largest market share in the geography segment for high definition breast tomosynthesis market. As per the research citings brought forward by the American Cancer Society (ACS) in 2019 in the United States approximately 268,600 new cases of breast cancer were reported among the women population. Existence of key players such as Hologic, Inc., GE Healthcare, Siemens Healthineers further propel the market growth pertaining to high definition breast tomosynthesis in the region. In Europe the number of breast cancer cases among the female population as diagnosed in 2018 was 562,500 according to the statistics of the European Breast Cancer Coalition. The strategic collaboration between academic research institutes and medical device manufacturers for the development of breast tomosynthesis devices. Asia Pacific is set to register impressive growth during the forecast period owing to the increasing public health awareness related to the benefits of early screening in breast cancer and developing healthcare infrastructure.

Medical device manufacturers pioneering in the production of high definition breast tomosynthesis are Siemens Healthineers, GE Healthcare, Fujifilm Corporation, Hologic, Inc., Agfa-Gevaert, IMS GIOTTO S.p.A., PLANMED OY., Dexela Ltd., Carestream Health and Metaltronica S.p.A.

Market Key Takeaways:

  • Rising prevalence of breast cancer worldwide
  • Technological advancement and up gradation in the breast tomosynthesis devices to achieve high-resolution images
  • Strategic collaboration between academic research institutes and medical device manufactures to develop high definition breast tomosynthesis devices

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Market Outlook Market Reports Market Research

Global Dietary Fiber Nutritional Supplements Market is expected to grow at a CAGR of 12.6% from 2020 to 2027

Nutritional science has undergone tremendous technical development in the last 5 decades eventually resulting in effective extraction from natural sources such as cereals, grains, fruits, and vegetables. Rising prevalence of gastrointestinal disorders, growing inclination for the consumption of unhealthy junk food, and sedentary lifestyle determines the dietary fiber nutritional supplements market growth. Proactive marketing of dietary fibers on social media will further accentuate the dietary fibers market growth in the near future.

The soluble dietary fibers are spearheading the type segment for dietary fiber nutritional supplements market. It is further sub-segmented as pectin, inulin, polydextrose, beta-glucan, etc. It usually forms a viscous gel-like substance when it comes in contact with the digestive fluid. It usually delays the digestion rate thereby reduces the feeling of hunger and food intake and is capable of maintaining a healthy weight. It has the ability to sequester blood cholesterol and is helpful in regulating blood glucose levels. It has been crucial in preventing the disease manifestation of chronic diseases such as cardiovascular disease and type 2 disease. Insoluble dietary fibers are gaining tremendous importance in their ability to maintain healthy gut flora and regulation of a peristaltic activity which is beneficial in treating chronic constipation.

Browse the full report Dietary Fiber Nutritional Supplements Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/dietary-fiber-nutritional-supplements-market

The supermarket is reigning the distribution channel segment in the dietary fiber nutritional supplements market. The chief contributing factors responsible for its market dominance are its inherent features such as lower operation and overhead cost and location in the central place of the city which attracts a huge customer base. It has the ability to display dietary fibers from several manufacturers and endorsed by different brands at competitive prices. E-commerce has gained tremendous traction in the last decade on account of a significant rise in the population using smartphones at the ability to reach a huge customer base with dietary fiber products at attractive discount rates.

North America is dominating the geography segment for the dietary fiber nutritional supplements market. The rising prevalence of the geriatric population suffering from gastrointestinal disorder primarily drives the market growth. Domicile of key players such as Archer Daniels Midland Company, BENEO, Cargill Corporation, DuPont, etc. further fortifies the dietary fiber nutritional supplements market in the region. Europe is in the 2nd place on account of the rising public health awareness regarding the useful application of insoluble fibers in achieving healthy gut microflora and peristaltic activity. The Asia Pacific is expected to register rampant market growth in the near future on account of the flourishing e-commerce segment which is providing a diverse range of dietary fiber products at affordable prices and attractive coupons.

Pharmaceutical companies manufacturing dietary fiber nutritional supplements are Archer Daniels Midland Company, Royal DSM, Citrucel, Robinson Pharma, Inc., BENEO, Cargill Corporation, Tate & Lyle, Plc., Viachem, Meron Group, and DuPont.

Market Key Takeaways:

  • Rising prevalence of gastrointestinal disorders in the elderly population worldwide
  • Increasing public health awareness regarding the useful application of prebiotics in maintaining healthy gut microflora and motility
  • Flourishing e-commerce segment providing a diverse range of dietary fibers at affordable prices and attractive coupons

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Market Reports Market Research

Global Potassium Clavulanate Market Is Expected to Grow At A CAGR of 3.2% from 2020 to 2027

Potassium clavulanate is a beta-lactamase inhibitor that increases the bactericidal activity of antibiotics used in combination for the treatment of various bacterial infections. It needs to be taken under medical supervision to avoid any drug-related toxicity.

Acute bacterial sinusitis is representing the largest market share in the clinical application segment for the potassium clavulanate market. According to the latest statistics provided by the World Health Organization (WHO), the global incidence rate of acute bacterial sinusitis is 30% worldwide. The disease progression takes place usually after an upper viral respiratory tract infection has already occurred with symptoms worsening after 5 days and being persistent in nature even after 10 days of initial infection. Community-acquired pneumonia is going to register rampant market growth during the forecast period on account of the rising prevalence of the disease in children below 5 years of age. As per the latest information provided by the National Institute of Health (NIH), approximately more than 5.9 million children die globally due to community-acquired pneumonia each year.

Browse the full report Potassium Clavulanate Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/potassium-clavulanate-market

Hospital pharmacy currently leading the distribution channel segment for potassium clavulanate market. The drug is often used in combination with other antibiotics to increase the spectrum of bactericidal activity against bacterial infections, thereby it is imperative for accurate dispensing of the drug formulation by the hospital pharmacist to prevent drug toxicity. Retail pharmacy is expected to highlight impressive market growth during the forecast period chiefly due to the sale of low-cost antibiotics due to government subsidy on essential medicine and its capacity to provide medicinal requirements on patients residing in remote locations.

North America is presently dominating the geography segment for the potassium clavulanate market. Rising prevalence of community-acquired pneumonia across all age groups primarily drives the market growth in the region. As per the recent research citings provided by the National Institute of Health (NIH), the annual incidence of community-acquired pneumonia in the United States is 24.8 per 10,000 individuals. The nurturing regulatory environment provided by the USFDA for the sale and distribution of potassium clavulanate drug formulation further accentuates the market growth in the region. Europe is placed in the 2nd position in the regional segment for the potassium clavulanate market. Affordable reimbursement scenario for the potassium clavulanate drug formulation determines the market growth in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment for potassium clavulanate market on account of the effective implementation of the treatment regimen pertaining to acute bacterial sinusitis and flourishing generic drugs market.

Pharmaceutical manufacturers actively engaged in the production of potassium clavulanate are Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Inc., Sandoz, Inc., GlaxoSmithKline, Plc., Mylan Pharmaceutical Industries Ltd., Dr. Reddys Laboratories Ltd., Macleods Pharmaceuticals Pvt Ltd., Cipla Ltd., Glenmark Pharmaceuticals Ltd., and Mankind Pharma.

Key Market Movements:

  • Rising prevalence of acute bacterial sinusitis infection worldwide
  • Significant increase in the number of children suffering from hospital-acquired pneumonia infection throughout the globe
  • Affordable reimbursement scenario for the potassium clavulanate drug formulation further accelerates the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Market Reports Market Research

Global Zirconium Dental Implants Market Is Expected To Grow At A CAGR Of 7.5% From 2020 To 2027

Zirconium dental implants are gaining huge demand in the dental surgery domain primarily due to its ability to hide the metallic color and luster owing to its diamond translucent color. The superior ergonomic features associated with zirconia are excellent strength, robustness, biocompatibility, corrosion resistance, etc. It is being designed by the latest CADCAM technology to achieve an accurate fit in the oral cavity.

An endosteal dental implant is currently leading the type segment for the zirconium dental implants market. It is the most common type of surgery performed by dentists worldwide. In this surgery usually the implant is directly inserted in the jawbone, and after the gum tissues are healed a second surgery is performed to connect the post to the original implant on which artificial tooth is mounted. In Subperiosteal implants the metal frame is usually placed in the jawbone just below the gums. When the gum tissue is healed the metal frame gets attached to the jawbone and the tooth is mounted on the protruding posts.

Browse the full report Zirconium Dental Implants Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/zirconium-dental-implants-market

Hospitals and clinics are spearheading the end-user segment for the zirconium dental implants market. The constant increase in the number of patients visiting dental facilities for treating dental deformities at subsidized prices in government-funded hospitals and clinics. The presence of well-equipped dental surgery kits and accessories further consolidates the market growth of hospitals and clinics. It is anticipated that the dental laboratories are going to gain huge market traction in the developing regions owing to the rising prevalence of dental caries associated with tobacco and betel nuts chewing and constant rise in the number of dental laboratories established in remote areas.

North America is presently representing the largest market share in the geography segment for the zirconium dental implants market. According to the latest statistics provided by the Center for Disease Control and Prevention (CDC), in the United States, the percentage of children and adults visiting the dentist for untreated dental caries is 84.9% and 64.0% respectively. The presence of major players such as 3M Company, Zimmer Biomet, and Dentsply Sirona, etc. further accelerates the zirconium dental implants market growth. In Europe the market growth is determined by the rising prevalence of edentulism in the geriatric population and proactive role adopted by the European Medical Agency for the early clearance of zirconium dental implants in the region. Asia Pacific is set to register impressive market growth in the near future on account of the significant rise in the medical tourism industry and a rise in per capita income of middle-income households.

Medical device manufacturers pioneering in the manufacturing of zirconium dental implants are Straumann Group, Zimmer Biomet, KYOCERA Corporation, Osstem Implants Company, Dentsply Sirona, TAV Dentsply Ltd., 3M Company, Nobel Biocare Services AG, Glidewell Dental and Z-Systems AG.

Market Key Takeaways:

Rising prevalence of dental deformities across all age group throughout the world

Technological advancement in the zirconium dental implants rendering it useful for Endosteal and subperiosteal dental implants

Supportive regulatory environment provided by the global regulatory agencies for its early clearance and adoption

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Market Outlook Market Reports Market Research

Global Amoxicillin Sodium Market Is Expected to Grow At A CAGR of 3.0% from 2020 to 2027

Amoxicillin sodium is considered as a broad-spectrum antibiotic having potent bactericidal activity. It exerts its pharmacological activity by binding to and inactivating the penicillin-binding proteins which are located in the inner membrane of the bacterial cell wall. It is enlisted in the World Health Organization (WHO) list of essential medicines.

Respiratory infections are reigning the clinical application segment for the amoxicillin sodium market. As per the latest information provided by the World Bank data in 2017, pneumonia is responsible for 15% of all the deaths occurring in children below 5 years of age worldwide. It is considered as first-line drug therapy for the treatment of lower respiratory tract infection. It is either used alone or in combination with potassium clavulanate for the treatment of ear and skin infections throughout the globe. Urinary tract infection is expected to record comfortable market growth during the forecast period owing to the rising prevalence of urinary tract infection caused due to E.coli infection. According to the recent research citings provided by the World Health Organization (WHO), the prevalence rate of community-associated urinary tract infection is 0.7% across the globe.

Browse the full report Amoxicillin Sodium Market  – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/amoxicillin-sodium-market

Hospital pharmacy is currently spearheading the distribution channel segment for the amoxicillin sodium market. The drug is a broad-spectrum antibiotics with different drug posology for different infections, hence precise drug compounding is mandatory to prevent the occurrence of any unwanted side effects. Retail pharmacy is keen to register rampant market growth in the near future on account of the availability of government-subsidized medicines at low prices and serves the medicinal requirements of people residing in remote locations.

North America is presently leading the geography segment for the amoxicillin sodium market. The rising prevalence of urinary tract infections primarily drives market growth in the region. As per the latest research citings presented by the Center for Disease Control and Prevention (CDC), approximately 40% of the women population in the United States is suffering from urinary tract infection annually. Furthermore, the domicile of key players such as Merck KGaA., Denton Pharma, Inc., Teva Pharmaceutical Industries Ltd., etc further propels the market growth. Europe is placed 2nd in the regional segment on account of the Nurturing regulatory environment provided by the European Medical Agency (EMA) of the rising prevalence of respiratory tract infections and affordable reimbursement scenario for the amoxicillin sodium drug products in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment for the amoxicillin sodium market. Flourishing generic drugs market and the emergence of local players together accentuate the market growth in the region.

Pharmaceutical manufacturers actively engaged in the production of amoxicillin sodium are Merck KGaA, Denton Pharma, Inc., Sandoz, Inc., Teva Pharmaceutical Industries Ltd., Wockhardt UK Ltd., Aurobindo Pharma Ltd., Alkem Labs., Mylan Pharmaceutical Industries Ltd., GlaxoSmithKline, Plc., and Sun Pharmaceutical Industries Ltd.

Key Market Movements:

  • A constant rise in the number of patients suffering from lower respiratory tract infections worldwide
  • Rising prevalence of urinary tract infection throughout the globe
  • Supportive regulatory environment provided by the healthcare agencies for the sale and use of amoxicillin sodium products

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Market Outlook Market Reports Market Research

Global Serotonin Supplements Market Is Expected to Grow At A CAGR of 7.7% from 2020 to 2027

Serotonin supplements that boost the natural production of serotonin in the human body are 5-hydroxytryptophan, tryptophan, s-adenosyl methionine, pyridoxine, folic acid, L-theanine, Rhodiola Rosea, Garcinia cambogia, etc. Rising public health awareness regarding the therapeutic efficacy of serotonin supplements in treating mental disorders and insomnia drives the market growth.

Anxiety and mood disorders are spearheading the clinical application segment for the serotonin supplements market. According to the latest statistics provided by the World Bank data in 2017, approximately 284 million people worldwide were reported to be suffering from an anxiety disorder. Further clinical research studies suggest that the prevalence rate of anxiety is 2.8% in males and 4.7% in females respectively. Mood disorder will be showcasing exemplary growth in the young population throughout the globe due to the consumption of alcohol, tobacco, ecstasy substances, stress, poor social life, etc. Insomnia will be highlighting steady market growth in the near future owing to the rising consumption of caffeinated products and psychological factors affecting mental health.

Browse the full report Serotonin Supplements Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/serotonin-supplements-market

Hypermarkets are currently dominating the distribution channel segment for the serotonin channel segments market. It serves as a lucrative market opportunity for consumers who believe in a one-stop shopping destination getting exposure to diverse product portfolios for serotonin supplements at affordable prices. Retail stores are considered as the most viable shopping option for consumers receiving a physician’s prescription for dietary supplements. E-commerce is expected to record excellent market growth during the forecast period owing to the adoption of smartphones by large consumer base worldwide and attractive discount coupons awarded on the purchase of dietary supplements and medicines on regular basis.

North America is presently leading the geography segment for the serotonin supplements market. The growing incidence of insomnia in the elderly population primarily drives the market growth in the region. According to the latest statistics provided by the Center for Disease Control and Prevention (CDC), approximately 1 in 4 American citizen develops insomnia each year. Domicile of key players such as Jarrow Formulas, Arazo Nutrition, Natrol, Swanson, etc. will further accentuate the market growth in the region. Europe is placed in the 2nd position in the regional segment owing to the rising prevalence of anxiety in the younger population. As per the latest information provided by the World Health Organization (WHO), each year approximately 25% population suffers from anxiety in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment for the serotonin supplements market. Flourishing traditional and herbal medicines enriched in 5HTP and tryptophan will steer the serotonin supplements market growth in the region.

Nutraceutical manufacturers actively engaged in the production of serotonin supplements are Jarrow Formulas, Arazo Nutrition, Natrol (Aurobindo Pharma USA, Inc.), Source Naturals, Solgar (Nature’s Bounty Co), Holland & Barrett (LetterOne), Swanson, The Genius Brand, Pure Encapsulation, Inc. (Nestle S.A.) and Scripts of Nature.

Key Market Movements:

  • Rising prevalence of anxiety and mood disorders worldwide
  • A constant rise in the number of elderly people suffering from insomnia throughout the globe
  • Rising public health awareness regarding the therapeutic efficacy of serotonin supplements in treating mental disorders and insomnia

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Market Outlook Market Reports Market Research

Global Dried Aluminium Hydroxide Gels Market Is Expected to Grow At A CAGR of 3.6% from 2020 to 2027

Dried aluminium hydroxide gel is also known as aluminium hydroxide gel, which is currently available as a generic drug and over the counter product in the various distribution channel. Citrate enriched food intake must be prevented while consuming aluminium hydroxide gel as it promotes excessive absorption of aluminium which is fatally toxic.

An antacid is presently reigning the clinical application segment for dried aluminium hydroxide gels market. The drug is a popular acid-neutralizing agent which is used in combination with other chemical moieties such as magnesium hydroxide and dimethicone for neutralizing excess hydrochloric acid present in the stomach environment. The dosage as an antacid for oral intake is liquid 320mg/5ml is 5 to 15 ml after every 6 hours. Hyperphosphatemia is expected to grow at a rampant pace owing to the growing incidence of hyperphosphatemia in patients suffering from chronic kidney diseases. The serum level of phosphorus is greater than 7mg/dl then use dried aluminium hydroxide gel for 4 to 6 weeks only depending on the dialysis clearance of phosphorus as the mean phosphorus binding is 22.3mg of phosphorus/5ml of aluminium hydroxide.

Browse the full report Dried Aluminium Hydroxide Gels Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/dried-aluminium-hydroxide-gels-market

Hospital pharmacy is currently leading the distribution channel segment for dried aluminium hydroxide gels market. Severe constipation, rash and nausea are the major side effects associated with dried aluminium hydroxide gel hence accurate dispensing by hospital pharmacist is imperative for patients suffering from acidity and heartburns. Retail pharmacy is keen to record impressive market growth owing to the constant surge observed in the over the counter (OTC) products and generic drugs market in the developing regions.

North America is presently dominating the geography segment for dried aluminium hydroxide gels market. Growing incidence of gastric indigestion primarily drives the market growth in the region. As per the latest statistics provided by the American College of Gastroenterology (ACG), approximately 60 million American complain about heartburn at least once a month. The supportive regulatory environment provided by the USFDA for the sale and distribution of dried aluminium gel products and affordable reimbursement scenario for the dried aluminium hydroxide gels drugs formulation together fortifies the market growth in the region. Europe is the second-largest regional segment on account of the effective collaboration between research academia and pharmaceutical companies to understand the therapeutic efficacy of dried aluminium hydroxide gel in the treatment of hyperphosphatemia in patients suffering from renal disease. Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period on account of flourishing over the counter (OTC) products market and the emergence of local players.

Pharmaceutical manufacturers actively engaged in the production of dried aluminium hydroxide gels are Kyowa Chemical Industry, SPI Pharma, Walgreen Company, Merck KGaA, Sanofi-Aventis, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Mylan Seiyaku and Sun Pharmaceuticals Ltd.

Key Market Movements:

  • Rising prevalence of gastric acidity worldwide
  • Significant increase in the number of hyperphosphatemia cases recorded worldwide in patients suffering from chronic kidney diseases
  • Affordable reimbursement scenario and availability of affordable over the counter products of dried aluminium hydroxide gel together bolster the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Market Reports Market Research

Global Avanafil Market Is Expected To Grow At A CAGR of 5.8% From 2020 To 2027

Avanafil is becoming very popular for the treatment of erectile dysfunction (ED) in comparison with other phosphodiesterase-5 (PDE5) inhibitors due to faster onset of action, longer duration of activity and excellent tolerability in elderly patients suffering from ED. The mechanism of action associated with the drug is that it inhibits cGMP specific phosphodiesterase type 5 (PDE5) and triggers cGMP mediated triggers smooth muscle relaxation and increase in the blood flow in the corpus cavernosum region of the penis.

In the present situation, the demographics of 60 years and above are dominating the Avanafil market. The erectile dysfunction (ED) is said to occur concomitantly with aging. The etiology associated with ED is complex and is said to be associated with anomalies associated with hormonal levels, vascular and smooth muscle functioning of corpus cavernosum. The demographics of the 21-39 age group are keen to register rampant market growth owing to the significant rise in smoking, alcoholism, obesity, and type 2 diabetes which results in reduced blood flow in the penile smooth muscles and stressful lifestyle drastically reducing sexual drive.

Browse the full report Avanafil Market  – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/avanafil-market

Hospital pharmacy is reigning the distribution channel segment for the Avanafil market. The major contributing factors responsible for its market growth are that is the first point of contact for patients to purchase physicians drug prescription. Availability of skilled pharmacists to dispense the right dosage of medicine according to the patient’s body mass index and thereby drastically reducing adverse events associated with high drug dosage. E-commerce is set to register faster market growth on account of the huge consumer base using smartphones and the ability to meet the medical requirements of patients in remote locations due to superior logistics.

North America is currently holding the largest market share in the geography segment for Avanafil market. According to the statistics provided by the pharmaceutical company Vivus, Inc., approximately more than 30 million men in the United States are suffering from erectile dysfunction. The constant rise in diabetic men population with reduced sexual drive will further propel the Avanafil market growth. Europe is in the 2nd position on account of the rising prevalence of erectile dysfunction across all age groups. As per the research citings brought forward by the European Association of Urology, the prevalence rate of erectile dysfunction in the European region is 19.2% and is anticipated to increase due to a significant rise in smoking, alcoholism, and diabetes. The Asia Pacific is keen to register healthy market growth for Avanafil due to a huge geriatric population base and provides lucrative market opportunities for major players to enter into licensing agreement with local players.

Pharmaceutical companies pioneering in the manufacture of Avanafil are Vivus, Inc., Metuchen Pharmaceuticals, Menarini Group, JW Pharmaceuticals, Acerus Pharmaceuticals, and Sunrise Remedies Private Limited.

Market Key Takeaways:

  • Rising prevalence of erectile dysfunction in elderly population throughout the globe
  • The constant rise of erectile dysfunction in middle-aged population due to the constant rise in obesity, smoking, alcoholism, and diabetes
  • Supportive regulatory environment for the market growth of Avanafil

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Market Reports Market Research

Global Deferasirox Market is expected to grow at a CAGR of 4.2% from 2020 to 2027

Deferasirox is an iron-chelating agent which is the most popular drug which is prescribed to reduce excess iron overload in blood disorder patients requiring frequent blood transfusion. It is available in different formulation for oral administration such as 90mg & 180mg film-coated tablets and tablet for suspension the composition are 125mg, 250mg, and 500mg, etc.

Transfusional hemosiderosis is spearheading the indication segment for the deferasirox market. Deposition of excess iron in the visceral organs such as liver, heart, and other endocrine glands takes place in the patients who receive blood transfusion for treating blood disorders such as sickle cell anemia, myelodysplastic syndrome, sickle cell anemia, etc. Deferasirox is recommended after the transfusion of 20 units of packed red blood cells or clinical evidence is reporting chronic iron overload for e.g. the serum ferritin level is greater than 1,000 µg/l associated with blood transfusion. Non-transfusion-dependent thalassemia syndromes are anticipated to be the rampant growing indication segment in the near future majorly due to the constant increase in the number of patients suffering from thalassemia syndromes. Deferasirox is recommended after clinical evidence has reported the iron overload as serum ferritin levels consistently greater than 800 µg/l in patients suffering from thalassemia syndromes.

Browse the full report Deferasirox Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/deferasirox-market

Hospital pharmacy is currently leading the distribution channel segment for the deferasirox market. Deferasirox is prescribed in different formulation and composition to reduce the burden associated with the chronic deposition of iron in the liver. Hospital pharmacist ensures precise compounding of deferasirox dose per body weight in order to reduce drug adverse events such as renal and hepatic function disorders etc. Retail pharmacy is becoming very popular in the developing regions due to the existence of competitive generic drugs market at affordable prices.

North America is currently reigning the geography segment for the deferasirox market. As per the statistics presented by the National Institute of Health (NIH), it is estimated that about 1% of the U.S. population is reported for suffering from nonmalignant blood disorders. Affordable reimbursement scenario for the deferasirox drug formulation used as an iron-chelating agent further propels the market growth in the region. Europe is in the 2nd largest market holder in the regional segment primarily due to the constant rise in the number of patients suffering from non-transfusion-dependent thalassemia syndromes. As per the research citings brought forward by the Health Programme of The European Union, the annual incidence of symptomatic cases associated with beta-thalassemia in the European Union is 1 per 10,000 people. The Asia Pacific will be the fastest-growing regional segment in the near future owing to the presence of a lucrative market for generic medicines and a constant rise in the number of patients suffering from chronic liver iron overload due to frequent blood transfusions.

Pharmaceutical manufacturers actively engaged in the production of deferasirox drug formulation are Novartis AG, Sun Pharmaceutical Industries Ltd., Apotex Corporation, Zydus Pharmaceuticals, Inc., Alembic Pharmaceuticals Limited., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories. Farma-Tek Pharmaceuticals. Bioprofarma Bagó, and AC Farma S.A.

Market Key Takeaways:

  • Significant rise in the number of blood-related disorders requiring frequent blood transfusion
  • Rising prevalence of beta-thalassemia major disorder worldwide
  • The supportive regulatory environment provided by the healthcare regulatory agencies pertaining to the sale and distribution of different formulation of deferasirox throughout the globe

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]